• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDOS INTERNATIONAL SARL STENT - VASCULAR RECONSTRUCTION; INTRACRANIAL NEUROVASCULAR STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDOS INTERNATIONAL SARL STENT - VASCULAR RECONSTRUCTION; INTRACRANIAL NEUROVASCULAR STENT Back to Search Results
Catalog Number UNKENTERPRISE
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Thromboembolism (2654)
Event Date 12/01/2010
Event Type  Injury  
Manufacturer Narrative
Manufacturer¿s ref.No: (b)(4).This complaint is from a literature source and the following citation was reviewed: kanaan h, jankowitz b, aleu a, kostov d, lin r, lee k, panipitiya n, gologorsky y, sandhu e, rissman l, crago e, chang yf, kim sr, jovin t, horowitz m.In-stent thrombosis and stenosis after neck-remodeling device-assisted coil embolization of intracranial aneurysms.Neurosurgery.2010 dec;67(6):1523-32; discussion 1532-3.Doi: 10.1227/neu.0b013e3181f8d194.Pmid: 21107183.Section d.4: the product catalog and lot numbers are not available / not reported.The unique identifier (udi) and expiration date of the device is not known.Section h.4: the device manufacture date is not known as the device lot number is not available / not reported.Although no specific intervention is stated, it is clinically reasonable to assume an intervention would be provided in the case of an occlusion at/near the stent site.The type of occlusion is not specified and being coded as a cerebral thrombosis.The event is being reported to the us fda as a conservative measure.This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by cerenovus, or its employees that the report constitutes an admission that the product, cerenovus, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Missing information from this report is identified as blank; this information was not provided in the reported event or available at the time of report submission.The manufacturer will submit a supplemental report if new facts arise which materially alter information submitted in a previous mdr report.Additional information will be submitted within 30 days of receipt.
 
Event Description
This complaint is from a literature source and the following citation was reviewed: kanaan h, jankowitz b, aleu a, kostov d, lin r, lee k, panipitiya n, gologorsky y, sandhu e, rissman l, crago e, chang yf, kim sr, jovin t, horowitz m.In-stent thrombosis and stenosis after neck-remodeling device-assisted coil embolization of intracranial aneurysms.Neurosurgery.2010 dec;67(6):1523-32; discussion 1532-3.Doi: 10.1227/neu.0b013e3181f8d194.Pmid: 21107183.Background and purpose: to examine the technical and anatomic factors that predict short- and longterm stent patency.We undertook a retrospective review of 161 patients who underwent coil embolization of 168 ruptured and unruptured aneurysms assisted by the use of a neckremodeling device.One hundred twenty-seven patients had catheter-based angiographic follow-up to evaluate 133 stent-coil constructs (mean, 15.4 months; median, 12.7 months).The technique of microcatheter jailing was used in a majority of patients; nonstandard stent configurations were also used.Cerenovus devices that were used in this study: qty unk: enterprise stents.Adverse event(s) and provided interventions associated with enterprise stent: qty 3: three patients using enterprise stents experienced in-stent thrombus.Treatments not listed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
STENT - VASCULAR RECONSTRUCTION
Type of Device
INTRACRANIAL NEUROVASCULAR STENT
Manufacturer (Section D)
MEDOS INTERNATIONAL SARL
chemin-blanc 38
le locle neuchatel CH-24 00
SZ  CH-2400
Manufacturer (Section G)
CERENOVUS INC
325 paramount dr
raynham MA 02767
Manufacturer Contact
kate karberg
31 technology dr
irvine, CA 92618
303552-689
MDR Report Key18530825
MDR Text Key333076263
Report Number3008114965-2024-00085
Device Sequence Number1
Product Code NJE
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
H60001
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Literature,Health Professional
Reporter Occupation Physician
Type of Report Initial
Report Date 01/17/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/17/2024
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberUNKENTERPRISE
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received01/04/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Life Threatening;
-
-